跳至主要内容
临床试验/IRCT2017041833506N1
IRCT2017041833506N1已完成2 期

Survey the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patient with benign prostatic hyperplasia

Sabzevar University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 6 years(—)
性别
Male

入选标准

  • Patients who refused to participate in the study and signed informed consent form; Age over 50 years;Symptoms of LUTS or urinary tract symptoms.Exclusion criteria: Discontent of continued cooperation with the study for any reason and at any stage of the research; Age less than 50 years; Proven history of prostate cancer; Prostatitis; Urethral obstruction caused by tumor; known tumor disease caused by lower urinary tract (bladder stones, neurogenic bladder, bladder cancer, urethral stricture); Surgery lower urinary tract (bladder, prostate and urethra); Nitrate consumption at the same time; Acute urinary retention after surgery

排除标准

  • 未提供

研究者

发起方
Sabzevar University of Medical Sciences

相似试验